Followers | 145 |
Posts | 27550 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Tuesday, July 07, 2009 3:20:27 PM
FOR IMMEDIATE RELEASE
Contact:
David W. Moskowitz MD
CEO, GenoMed
dwmoskowitz@genomed.com
Tel. 314.983.9938
ST. LOUIS—July 7, 2009—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that it is part of a white paper which the House of Lords Subcommittee on Genomics and Medicine issued today.
The House of Lords Committee on Science and Technology, Subcommittee on Genomic Medicine, issued a white paper today which encourages the National Health Service to make use of the advances in genomic medicine sooner rather than later (http://tinyurl.com/HouseOfLordsGenomicReport).
GenoMed contributed to this report (http://tinyurl.com/GMEDwhitepaper), identifying specific ways in which any patient population could take advantage of what's already known about genomic medicine.
David W. Moskowitz, MD FACP, GenoMed's CEO, said "We're delighted to have our contribution included in the House of Lords' White Paper. As the pioneer in bringing genomic medicine to the clinic, GenoMed is in a unique position to improve patient outcomes and lower healthcare costs. Our program to eliminate dialysis around the world by 2014 is a perfect example (http://tinyurl.com/nodialysis)."
Added Dr. Moskowitz, "I hope the British National Health Service, as well as Medical Directors in charge of patient populations everywhere, read the House of Lords' White Paper. Together, we can make our dream of eliminating 90% of kidney failure in 5 years a reality."
About GenoMed
GenoMed is a Next Generation Disease Management company that aims to deliver the best patient outcomes at the lowest possible cost. As the only Public Health Company™ in the world, GenoMed aims to arrest diabetes, hypertension, and emphysema globally. No genotyping is required for these diseases. Please contact Dr. Moskowitz if you have one of these diseases.
About the House of Lords
The House of Lords began phasing out life-time, hereditary membership under the leadership of Prime Minister Tony Blair, and replacing peers with experts who had achieved distinction in their respective fields. This has enabled the House of Lords to provide expert advice to the House of Commons and the Executive Branch of British government, including the National Health Service.
Recent GMED News
- Globus Medical Schedules First Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 04/16/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:07:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 11:50:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:35:42 PM
- Globus Medical Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 02/20/2024 09:15:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:08:54 PM
- Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • GlobeNewswire Inc. • 02/13/2024 10:17:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 06:08:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:45:09 PM
- Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer • GlobeNewswire Inc. • 02/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:11:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:09:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:06:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:58:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:55:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:50:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:46:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:43:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:39:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:37:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:33:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 09:52:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:35:05 PM
- Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results • GlobeNewswire Inc. • 01/10/2024 09:30:00 PM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM